title: Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty.
abstract: Treatment of restenosis after angioplasty with octapeptide somatostatin (SST) analogs has met with variable success. These analogs bind with high affinity to only two SST receptor (SSTR) subtypes (2 and 5), display moderate affinity for SSTR3, and low affinity for SSTR1 and 4. To optimize the vasculoprotective effect of SST, we have investigated the pattern of expression of all five SSTRs in rat thoracic aorta in the resting state and at 15 min, 3, 7, and 14 days after balloon endothelial denudation. SSTR1-5 were analyzed as mRNA by semiquantitative reverse transcriptase-polymerase chain reaction and as protein by immunocytochemistry. All five SSTRs were expressed in rat aorta both as mRNA and protein and displayed a time-dependent, subtype-selective response to endothelial denudation. mRNA for SSTR1 and 2 increased acutely (SSTR1 > SSTR2) on days 3 and 7, coincident with smooth muscle cell (SMC) proliferation, and declined to basal levels by day 14. SSTR3 and 4 displayed a different pattern with a delayed, more gradual increase in mRNA beginning at days 3-7 and continued to increase thereafter. SSTR5 mRNA was constitutively expressed at a low level and showed no change during the 2 wk postinjury period. By immunohistochemistry, SSTR1-5 antigens were localized predominantly in SMC that were present in the media or had migrated into the intima; antigen expression correlated with receptor mRNA expression. Notably, only SSTR1,3,4 were expressed in the intima: SSTR1 and 4 during the proliferative burst and SSTR3 and 4 after proliferation, when SMC migration into the intima continues. These results demonstrate dynamic changes in SSTR1-5 expression after vascular trauma localized to areas of vascular SMC migration and replication. In view of their early and prominent induction, SSTR1 may be the optimal subtype to target for inhibition of myointimal proliferation, and SSTR3 and 4 for migration and remodeling.
authors.affiliation: Fraser Laboratories, Department of Medicine, McGill University, Royal Victoria Hospital, Montreal, Quebec, H3A 1A1 Canada.
authors.forename: S
authors.initials: S
authors.lastname: Khare
authors.forename: U
authors.initials: U
authors.lastname: Kumar
authors.forename: R
authors.initials: R
authors.lastname: Sasi
authors.forename: L
authors.initials: L
authors.lastname: Puebla
authors.forename: L
authors.initials: L
authors.lastname: Calderon
authors.forename: K
authors.initials: K
authors.lastname: Lemstrom
authors.forename: P
authors.initials: P
authors.lastname: Hayry
authors.forename: A Y
authors.initials: AY
authors.lastname: Patel
mesh_terms: D000800:Angioplasty, Balloon; D000818:Animals; D001011:Aorta / Q000378:metabolism* / Q000473:pathology; D002455:Cell Division; D005786:Gene Expression Regulation; D007150:Immunohistochemistry; D008297:Male; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D017481:Receptors, Somatostatin / Q000096:biosynthesis* / Q000235:genetics